Transition Technologies Science
Transition Technologies Science is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
Multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of rapamycin in drug-resistant epilepsy associated with TSC (RaRE-TS)
Sponsor Instytut Pomnik Centrum Zdrowia Dziecka
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomized, placebo-controlled, double-blind and double-dummy clinical trial comparing the safety, tolerability, and efficacy of vigabatrin and rapamycin in a preventive treatment of infants with Tuberous Sclerosis Complex
Sponsor Instytut Pomnik Centrum Zdrowia Dziecka
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Transition Technologies Science?
The 2026-10-09 snapshot links Transition Technologies Science to 2 distinct CTIS trials. Recorded services include Data management, Statistical analysis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Transition Technologies Science?
The most frequently recorded therapeutic areas are Genetic and Congenital Disorders, Neurology. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Transition Technologies Science conducted?
The linked trials record locations in 1 country, including Poland. These are trial locations, not confirmed office locations or countries where Transition Technologies Science delivered services.
What can this page tell me about Transition Technologies Science's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Transition Technologies Science. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Transition Technologies Science